(Q51614631)
Statements
MEGX (monoethylglycinexylidide): a novel in vivo test to measure early hepatic dysfunction after hypovolemic shock (English)
B Chandel
M J Shapiro
M Kurtz
W U Rana
M Matthews
M Jellinek
51-3; discussion 54-5